StonvexLoading…
StonvexStonvexStonvexCore line items from AVPT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $419.50M | $330.48M | $271.82M | $232.34M |
Operating Income | $33.03M | $7.17M | $-15.35M | $-41.07M |
Net Income | $34.80M | $-29.09M | $-21.73M | $-41.63M |
EPS (Diluted) | $0.15 | $-0.16 | $-0.12 | $-0.23 |
Total Assets | $789.18M | $519.05M | $442.58M | $415.53M |
Total Liabilities | $310.48M | $248.11M | $217.74M | $172.38M |
Cash & Equivalents | $481.06M | $290.74M | $223.16M | $227.19M |
Free Cash Flow OCF − CapEx | $81.57M | $85.85M | $32.61M | $-4.63M |
Shares Outstanding | 215.08M | 194.07M | 184.65M | 185.28M |